Abstract
We have recently seen impressive methodological developments in quantitative cardiovascular physiology and pathophysiology, with novel mathematical models for the mechanical and electrophysiological processes of the heart, and fluid dynamical models to describe the pressure and flow distribution in the blood vessel network. This allows us to gain deeper insight into the state of a variety of serious cardiovascular diseases. The majority of recent research studies have focused on the forward problem: developing flexible mathematical models and robust numerical simulation procedures to match characteristics of physiological target data, and the inverse problem: inferring model parameters from cardiac physiological data with reliable uncertainty quantification. However, when connecting mathematical model predictions and statistical inference to the clinical decision process, new challenges arise. This paper briefly discusses the complications that potentially result from closed-loop effects, and the model extensions that are required to reduce the ensuing bias.
Introduction: The Observer Effect in Medical AI
In the field of computational physiology, researchers typically focus on two areas: the forward problem (building models that simulate biology) and the inverse problem (using data to infer hidden biological parameters, like arterial stiffness). However, a significant gap exists when these models are used in real-world clinical settings.
This paper highlights a critical "observer effect": when a clinical decision support system (CDSS) triggers a treatment, that treatment alters the patient's physiology, which in turn biases the data the system uses for future predictions. If the model updates its parameters without accounting for this external intervention, it produces biased results, essentially interpreting a drug-induced improvement as a decrease in underlying disease severity.
Methodology: Modeling the Feedback Loop
The authors propose a mathematical framework to account for these closed-loop effects by framing clinical support as a dynamic system.
Their approach involves:
- Biophysical Modeling: Using 1D fluid dynamics (Partial Differential Equations) to describe blood flow and pressure across a vessel network, complemented by Windkessel lumped-parameter models to simulate distal resistance.
- Statistical Inference: Employing Markov Chain Monte Carlo (MCMC) methods to infer vessel stiffness—a key indicator of disease that cannot be measured directly.
- Closed-Loop Correction: In simulation, when pressure exceeds a threshold, an "in-silico vasodilator" increases vessel diameter. The "corrected" model includes this diameter change in its inference equations, while a "naive" model assumes the diameter remains constant.
Key Results
The study demonstrates that ignoring the treatment effect creates a systematic bias that makes patients appear healthier than they actually are. This bias is particularly damaging when estimating hidden mechanical properties like vessel stiffness.
As shown in the table below, the error in the naive model explodes as the clinical situation becomes more severe and interventions become more aggressive.
At a 75% risk threshold, the naive model's error reached 61.5%, drastically underestimating vessel stiffness. In contrast, the "Closed-loop correction" reduced the estimation error to near zero (-0.26%) across all thresholds.
Discussion and Future Work
While this study uses mouse geometry and simulated data, it proves that closed-loop modeling becomes exponentially more important as patient risk increases. Future work must focus on integrating real-time clinical logs—tracking exactly when and how much medication was administered—directly into the MCMC inference pipeline to provide unbiased, real-time decision support for human cardiovascular systems.
Summary updated